172 related articles for article (PubMed ID: 12203839)
1. Analysis of the interaction between the aspartic peptidase inhibitor SQAPI and aspartic peptidases using surface plasmon resonance.
Farley PC; Christeller JT; Sullivan ME; Sullivan PA; Laing WA
J Mol Recognit; 2002; 15(3):135-44. PubMed ID: 12203839
[TBL] [Abstract][Full Text] [Related]
2. Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans.
Backman D; Danielson UH
Biochim Biophys Acta; 2003 Mar; 1646(1-2):184-95. PubMed ID: 12637026
[TBL] [Abstract][Full Text] [Related]
3. His374 of wheat endoxylanase inhibitor TAXI-I stabilizes complex formation with glycoside hydrolase family 11 endoxylanases.
Fierens K; Gils A; Sansen S; Brijs K; Courtin CM; Declerck PJ; De Ranter CJ; Gebruers K; Rabijns A; Robben J; Campenhout S; Volckaert G; Delcour JA
FEBS J; 2005 Nov; 272(22):5872-82. PubMed ID: 16279951
[TBL] [Abstract][Full Text] [Related]
4. Slow-tight binding inhibition of pepsin by an aspartic protease inhibitor from Streptomyces sp. MBR04.
Menon V; Rao M
Int J Biol Macromol; 2012; 51(1-2):165-74. PubMed ID: 22522047
[TBL] [Abstract][Full Text] [Related]
5. NMR study of the inhibition of pepsin by glyoxal inhibitors: mechanism of tetrahedral intermediate stabilization by the aspartyl proteases.
Cosgrove S; Rogers L; Hewage CM; Malthouse JP
Biochemistry; 2007 Oct; 46(39):11205-15. PubMed ID: 17824620
[TBL] [Abstract][Full Text] [Related]
6. Biosensor-based screening and characterization of HIV-1 inhibitor interactions with Sap 1, Sap 2, and Sap 3 from Candida albicans.
Backman D; Monod M; Danielson UH
J Biomol Screen; 2006 Mar; 11(2):165-75. PubMed ID: 16418316
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the squash aspartic acid proteinase inhibitor (SQAPI) and mutational analysis of pepsin inhibition.
Headey SJ; MacAskill UK; Wright MA; Claridge JK; Edwards PJB; Farley PC; Christeller JT; Laing WA; Pascal SM
J Biol Chem; 2010 Aug; 285(35):27019-27025. PubMed ID: 20538608
[TBL] [Abstract][Full Text] [Related]
8. Biophysical characterization of the interaction of the beta-lactamase TEM-1 with its protein inhibitor BLIP.
Albeck S; Schreiber G
Biochemistry; 1999 Jan; 38(1):11-21. PubMed ID: 9890878
[TBL] [Abstract][Full Text] [Related]
9. Purification of a novel pepsin inhibitor from Coriolus versicolor and its biochemical properties.
Zhang GQ; Zhang QP; Sun Y; Tian YP; Zhou ND
J Food Sci; 2012 Mar; 77(3):C293-7. PubMed ID: 22384953
[TBL] [Abstract][Full Text] [Related]
10. Structural and mechanistic insight into the inhibition of aspartic proteases by a slow-tight binding inhibitor from an extremophilic Bacillus sp.: correlation of the kinetic parameters with the inhibitor induced conformational changes.
Dash C; Phadtare S; Deshpande V; Rao M
Biochemistry; 2001 Sep; 40(38):11525-32. PubMed ID: 11560501
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of a low molecular weight aspartic protease inhibitor from thermo-tolerant Bacillus licheniformis: kinetic interactions with Pepsin.
Kumar A; Rao M
Biochim Biophys Acta; 2006 Dec; 1760(12):1845-56. PubMed ID: 16982155
[TBL] [Abstract][Full Text] [Related]
12. Insight into the structural similarity between HIV protease and secreted aspartic protease-2 and binding mode analysis of HIV-Candida albicans inhibitors.
Calugi C; Guarna A; Trabocchi A
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):936-43. PubMed ID: 22803674
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of unsymmetrical peptidyl urea inhibitors of aspartic peptidases.
Dales NA; Bohacek RS; Satyshur KA; Rich DH
Org Lett; 2001 Jul; 3(15):2313-6. PubMed ID: 11463304
[TBL] [Abstract][Full Text] [Related]
14. Recombinant prosegment peptide acts as a folding catalyst and inhibitor of native pepsin.
Dee DR; Filonowicz S; Horimoto Y; Yada RY
Biochim Biophys Acta; 2009 Dec; 1794(12):1795-801. PubMed ID: 19715777
[TBL] [Abstract][Full Text] [Related]
15. Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2.
Degel B; Staib P; Rohrer S; Scheiber J; Martina E; Büchold C; Baumann K; Morschhäuser J; Schirmeister T
ChemMedChem; 2008 Feb; 3(2):302-15. PubMed ID: 18038380
[TBL] [Abstract][Full Text] [Related]
16. Purification, characterization and cloning of an aspartic proteinase inhibitor from squash phloem exudate.
Christeller JT; Farley PC; Ramsay RJ; Sullivan PA; Laing WA
Eur J Biochem; 1998 May; 254(1):160-7. PubMed ID: 9652409
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.
Ng KK; Petersen JF; Cherney MM; Garen C; Zalatoris JJ; Rao-Naik C; Dunn BM; Martzen MR; Peanasky RJ; James MN
Nat Struct Biol; 2000 Aug; 7(8):653-7. PubMed ID: 10932249
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age.
Hoegl L; Korting HC; Klebe G
Pharmazie; 1999 May; 54(5):319-29. PubMed ID: 10368824
[TBL] [Abstract][Full Text] [Related]
19. Construction, expression and characterization of a chimaeric mammalian-plant aspartic proteinase.
Payie KG; Tanaka T; Gal S; Yada RY
Biochem J; 2003 Jun; 372(Pt 3):671-8. PubMed ID: 12630913
[TBL] [Abstract][Full Text] [Related]
20. Nonspecific electrostatic binding of substrates and inhibitors to porcine pepsin.
Kuzmic P; Sun CQ; Zhao ZC; Rich DH
Adv Exp Med Biol; 1991; 306():75-86. PubMed ID: 1812761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
